4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-23-003706
Chief Executive Officer sold 34,446 shares at an average $20.61 ($709,873)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirn David Chief Executive Officer | 2023-02-21 | Sale | −17,090 | $20.93 | $357,718 | 1,876,509 | D: show line 1 in the form |
| Kirn David Chief Executive Officer | 2023-02-21 | Sale | −907 | $21.49 | $19,491 | 1,875,602 | D: show line 2 in the form |
| Kirn David Chief Executive Officer | 2023-02-22 | Sale | −16,449 | $20.22 | $332,665 | 1,859,153 | D: show line 3 in the form |
| Open-market sales · 34,446 sh · avg $20.61 · $709,873 | |||||||
Loading xslF345X03/doc1.xml…